pilapharma.com

Pila Pharma Ab


Pila Pharma AB is developing a new class of orally active drugs for the treatment of newly diagnosed type 2 diabetes. PILA PHARMA is a privately held clinical stage pharmaceutical company based in Malmö, Sweden. PILA PHARMA is developing a novel type of oral anti-diabetic agent: a TRPV1 antagonist for the treatment of diabetes. The company owns issued use-patents giving the right to treat diabetes and obesity with TRPV1 antagonists. Our safe clinical development candidate, XEN-D0501, entered the first clinical trials in type-2 diabetic patients in 2017.
View Top Employees for Pila Pharma Ab
img Website pilapharma.com
img Industry Biotechnology
img Location Malmö, Skåne, Sweden
img Employees 8
img Founded 2014
img HQ Medeon Science Park Per Albin Hanssons väg 41
img Funding 81,868 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Website pilapharma.com
img Industry Biotechnology
img Location Malmö, Skåne, Sweden
img Employees 8
img Founded 2014
img LinkedIn linkedin.com/company/pila-pharma-ab
img HQ Medeon Science Park Per Albin Hanssons väg 41
img Funding 81,868 USD

Top Pila Pharma Ab Employees